Acumen Pharmaceuticals, Inc. (NASDAQ:ABOS) Q4 2023 Earnings Call Transcript

Operator: Ladies and gentlemen. Thank you for standing by. Welcome to Acumen Pharmaceuticals Full Year 2023 Conference Call and Webcast. At this time, all participants are in a listen-only mode.

Related Keywords

Lisbon ,Lisboa ,Portugal ,United States ,American ,Dan Oconnell ,Alex Braun ,Daniel Oconnell ,Matt Zuga ,Neena Bitritto Garg ,Eric Siemers ,Donanemab Adcomm ,Paul Matteis ,Colin Bristow ,Jim Doherty ,Thomas Shrader ,Matthew Zuga ,Welcome To Acumen Pharmaceuticals Full Year ,Nasdaq ,American Academy Of Neurology Meeting In Denver ,Acumen Pharmaceuticals Inc ,Development Officer ,Acumen Pharmaceuticals ,Call Transcript March ,Acumen Pharmaceuticals Full Year ,Dano Connell ,Chief Executive Officer ,Chief Development Officer ,Chief Medical Officer ,Chief Financial Officer ,Chief Business ,Federal Securities Laws ,Early Alzheimer ,Chief Development ,American Academy ,Neurology Meeting ,Unlikea Beta ,Richest Women ,Billionaires Who Inherited ,Maybei Ll ,